ONCY CIK: 1129928

Oncolytics Biotech Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY24
FY25
FY24 – FY25

Assets

(positive)
Change from FY24 to FY25
millions USD
FY24:
12.4
FY25:
6.84
(positive)
Change from FY24 to FY25
millions USD
FY24:
0.99
FY25:
0.74
Total assets
Change from FY24 to FY25
millions USD
FY24:
13.4
FY25:
7.58

Liabilities & Equity

(negative)
Change from FY24 to FY25
millions USD
FY24:
4.89
FY25:
6.10
(negative)
Change from FY24 to FY25
millions USD
FY24:
5.24
FY25:
5.28
(positive)
Change from FY24 to FY25
millions USD
FY24:
3.30
FY25:
−3.80
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY24:
13.4
FY25:
7.58

All amounts in millions USD Data source:SEC EDGAR